CVS Health Corp (CVS) Stock Price Today
Aura AI Summary
Key Stats
- $135.89BMarket Cap
- -Volume
- HealthSector
- $106.5052W High
- $58.7552W Low
- -Typical Hold Time
- $202.43BEnterprise Value
- 2.5%Div Yield
- -Trading Activity
Track CVS Health Corp (CVS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, CVS Health Corp has traded between a low of $58.75 and a high of $108.09, highlighting its annual price range. Buy and sell CVS Health Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Most Recent News
Military drone market to grow to $109B by 2031, driven by AI, defense budgets, and geopolitical tensions
The global military drone market is projected to expand from $34.85 billion in 2026 to $109.22 billion by 2031, growing at a CAGR of 25.7%. Growth is fueled by rising defense budgets, demand for intelligence, surveillance, reconnaissance (ISR), preci...
Global financial analytics market to triple to $36.1B by 2035 driven by AI, cloud, and predictive tech.
The global financial analytics market, valued at $12.15 billion in 2025, is projected to grow to $36.10 billion by 2035 at a CAGR of 11.5%. Growth is fueled by increasing adoption of AI, machine learning, cloud computing, and predictive analytics acr...
Global muscle stimulator market to reach $1.16B by 2035, driven by rising demand in pain management and rehab.
The global muscle stimulator market is projected to grow from $812 million in 2025 to $1.16 billion by 2035, at a CAGR of 3.6%. Growth is fueled by increasing use of neuromuscular electrical stimulation devices for pain management, sports rehabilitat...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.